Биомаркеры в диагностике и мониторинге лечения болезней клеточных органелл

Tatiana Krylova, Т. Ю. Прошлякова, Г.В. Байдакова et al. · 2016

Biomarkers (BM) are biological molecules that can indicate the presence of a biological process linked to the clinical manifestations of disease. This review was focused on present information about biomarkers for three groups of hereditary metabolic diseases related to the disorders of the cell organelles - lysosomal storage disorders (LSD), mitochondrial and peroxisomal disorders. Enzyme replacement therapy and other treatments are being introduced for lysosomal storage diseases (LSDs). However, apart from in Gaucher disease, there are currently very few biomarkers that are available to monitor LSDs and other disorders of cell’s organelles. In conclusion we can note, that biomarkers have a clear application in routine clinical monitoring after the developing of new drugs - and at the same time may provide opportunities for a better understanding of molecular pathogenesis of inherited diseases and developing of new treatments.

Cited by 0 works. doi:10.1234/xxxx-xxxx-2016-7-3-10

Authors